Literature DB >> 19524725

Prevalence of gastroschisis and associated hospital time continue to rise in neonates who are admitted for intensive care.

Reese H Clark1, M Whit Walker, Michael W L Gauderer.   

Abstract

PURPOSE: The purpose of this study was to evaluate recent trends in the prevalence of gastroschisis.
METHODS: The study used a retrospective review of a deidentified neonatal intensive care patient data set. To control for ascertainment bias, the prevalence of omphalocele was calculated to provide an internal comparison to another anomaly requiring surgical intervention.
RESULTS: During the study period (1997-2007), there were 473,366 discharges from the neonatal intensive care unit in the data set. There were 2057 (5.3/1000 discharges) neonates who had a gastroschisis and 853 (1.8/1000 discharges) who had an omphalocele. Between 1997 and 2004, the reported rate of gastroschisis increased from 2.9 to 6.1/1000 discharges, a relative increase of 210% (P < .001). Since 2004, the values have remained relatively stable at between 5.5 and 6.2/1000 discharges. Between 1997 and 2007, the hospital days for patients with gastroschisis/total hospital days increased from 0.6% to 1.3%, a relative increase of 220% (P < .001). In contrast, the reported rate of neonates with and the number of hospital days attributed to neonates with omphalocele has not changed significantly.
CONCLUSION: The prevalence and the number of hospital days needed to care for neonates with gastroschisis have continued to increase since 2001.

Entities:  

Mesh:

Year:  2009        PMID: 19524725     DOI: 10.1016/j.jpedsurg.2009.02.018

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  9 in total

1.  Ward reduction of gastroschisis: risk stratification helps optimise the outcome.

Authors:  Kate Leadbeater; Rajendra Kumar; Rob Feltrin
Journal:  Pediatr Surg Int       Date:  2010-10       Impact factor: 1.827

Review 2.  Gastroschisis: an update.

Authors:  Andrew J A Holland; Karen Walker; Nadia Badawi
Journal:  Pediatr Surg Int       Date:  2010-08-05       Impact factor: 1.827

Review 3.  Working group reports: evaluation of the evidence to support practice guidelines for nutritional care of preterm infants-the Pre-B Project.

Authors:  Daniel J Raiten; Alison L Steiber; Susan E Carlson; Ian Griffin; Diane Anderson; William W Hay; Sandra Robins; Josef Neu; Michael K Georgieff; Sharon Groh-Wargo; Tanis R Fenton
Journal:  Am J Clin Nutr       Date:  2016-01-20       Impact factor: 7.045

4.  Infectious complications in the management of gastroschisis.

Authors:  Robert Baird; Pramod Puligandla; Erik Skarsgard; Jean-Martin Laberge
Journal:  Pediatr Surg Int       Date:  2011-12-08       Impact factor: 1.827

5.  The epidemiology, prevalence and hospital outcomes of infants with gastroschisis.

Authors:  R Allman; J Sousa; M W Walker; M M Laughon; A R Spitzer; R H Clark
Journal:  J Perinatol       Date:  2016-07-07       Impact factor: 2.521

6.  Interval growth across gestation in pregnancies with fetal gastroschisis.

Authors:  Kathy Zhang-Rutledge; Marni Jacobs; Elizabeth Patberg; Nancy Field; Kerry Holliman; Katie M Strobel; Aisling Murphy; Diana Robles; Naseem Rangwala; Juan M Gonzalez; Teresa N Sparks
Journal:  Am J Obstet Gynecol MFM       Date:  2021-05-31

7.  Frequency of anomalies and hospital outcomes in infants with gastroschisis and omphalocele.

Authors:  Kristin M Corey; Christoph P Hornik; Matthew M Laughon; Kerstin McHutchison; Reese H Clark; P Brian Smith
Journal:  Early Hum Dev       Date:  2014-06-11       Impact factor: 2.699

8.  Outcome and management in neonates with gastroschisis in the third millennium-a single-centre observational study.

Authors:  Lotta Räsänen; Helene Engstrand Lilja
Journal:  Eur J Pediatr       Date:  2022-02-28       Impact factor: 3.860

9.  Prevalence and correlates of gastroschisis in 15 states, 1995 to 2005.

Authors:  Russell S Kirby; Jennifer Marshall; Jean Paul Tanner; Jason L Salemi; Marcia L Feldkamp; Lisa Marengo; Robert E Meyer; Charlotte M Druschel; Russel Rickard; James E Kucik
Journal:  Obstet Gynecol       Date:  2013-08       Impact factor: 7.623

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.